Opioids: an unexplored option for treatment of dyspnea in IPF

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is the most common among the idiopathic interstitial pneumonias and has the worst prognosis, with a median survival of 3–5 years. The most common symptom in IPF is dyspnea, impacting on the patient's quality of life and life expectancy. Morphine i...

Descripción completa

Detalles Bibliográficos
Autores principales: Kohberg, Charlotte, Andersen, Charlotte Uggerhøj, Bendstrup, Elisabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Co-Action Publishing 2016
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4788766/
https://www.ncbi.nlm.nih.gov/pubmed/26969472
http://dx.doi.org/10.3402/ecrj.v3.30629

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4788766/
https://www.ncbi.nlm.nih.gov/pubmed/26969472
http://dx.doi.org/10.3402/ecrj.v3.30629

Ejemplares similares